246 related articles for article (PubMed ID: 16896035)
1. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
[TBL] [Abstract][Full Text] [Related]
2. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians.
Gallagher CJ; Kadlubar FF; Muscat JE; Ambrosone CB; Lang NP; Lazarus P
Cancer Detect Prev; 2007; 31(4):310-5. PubMed ID: 17935910
[TBL] [Abstract][Full Text] [Related]
3. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate.
Karypidis AH; Olsson M; Andersson SO; Rane A; Ekström L
Pharmacogenomics J; 2008 Apr; 8(2):147-51. PubMed ID: 17387331
[TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
Park JY; Tanner JP; Sellers TA; Huang Y; Stevens CK; Dossett N; Shankar RA; Zachariah B; Heysek R; Pow-Sang J
Urology; 2007 Aug; 70(2):374-9. PubMed ID: 17826523
[TBL] [Abstract][Full Text] [Related]
5. The UGT2B17 gene deletion is not associated with prostate cancer risk.
Olsson M; Lindström S; Häggkvist B; Adami HO; Bälter K; Stattin P; Ask B; Rane A; Ekström L; Grönberg H
Prostate; 2008 Apr; 68(5):571-5. PubMed ID: 18247404
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.
Eskandari-Nasab E; Hashemi M; Rezaei H; Fazaeli A; Mashhadi MA; Moghaddam SS; Arbabi F; Jahantigh M; Taheri M
Mol Biol Rep; 2012 Dec; 39(12):10531-9. PubMed ID: 23053953
[TBL] [Abstract][Full Text] [Related]
7. A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
Hu DG; Gardner-Stephen D; Severi G; Gregory PA; Treloar J; Giles GG; English DR; Hopper JL; Tilley WD; Mackenzie PI
Mol Pharmacol; 2010 Oct; 78(4):714-22. PubMed ID: 20628005
[TBL] [Abstract][Full Text] [Related]
8. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism.
Jakobsson J; Ekström L; Inotsume N; Garle M; Lorentzon M; Ohlsson C; Roh HK; Carlström K; Rane A
J Clin Endocrinol Metab; 2006 Feb; 91(2):687-93. PubMed ID: 16332934
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15.
Wilson W; Pardo-Manuel de Villena F; Lyn-Cook BD; Chatterjee PK; Bell TA; Detwiler DA; Gilmore RC; Valladeras IC; Wright CC; Threadgill DW; Grant DJ
Genomics; 2004 Oct; 84(4):707-14. PubMed ID: 15475248
[TBL] [Abstract][Full Text] [Related]
10. Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.
Zhu AZ; Cox LS; Ahluwalia JS; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
Pharmacogenet Genomics; 2015 May; 25(5):263-9. PubMed ID: 25794161
[TBL] [Abstract][Full Text] [Related]
11. The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.
Angstadt AY; Berg A; Zhu J; Miller P; Hartman TJ; Lesko SM; Muscat JE; Lazarus P; Gallagher CJ
Cancer; 2013 Jul; 119(13):2477-85. PubMed ID: 23575887
[TBL] [Abstract][Full Text] [Related]
12. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.
Park J; Chen L; Shade K; Lazarus P; Seigne J; Patterson S; Helal M; Pow-Sang J
J Urol; 2004 Jun; 171(6 Pt 1):2484-8. PubMed ID: 15126881
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.
Cai L; Huang W; Chou KC
Protein Pept Lett; 2012 Jan; 19(1):62-9. PubMed ID: 21919858
[TBL] [Abstract][Full Text] [Related]
14. UDP-glucuronosyltransferase 2B17 genotype and the risk of lung cancer among Austrian Caucasians.
Gruber M; Le T; Filipits M; Gsur A; Mannhalter C; Jäger U; Vanura K
Cancer Epidemiol; 2013 Oct; 37(5):625-8. PubMed ID: 23850147
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.
Habibi M; Mirfakhraie R; Khani M; Rakhshan A; Azargashb E; Pouresmaeili F
Gene; 2017 Nov; 634():47-52. PubMed ID: 28882566
[TBL] [Abstract][Full Text] [Related]
16. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
[TBL] [Abstract][Full Text] [Related]
17. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
[TBL] [Abstract][Full Text] [Related]
18. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer.
Gallagher CJ; Muscat JE; Hicks AN; Zheng Y; Dyer AM; Chase GA; Richie J; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):823-8. PubMed ID: 17416778
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Leathart JB; Navidi WC; Carpenter CC; Idle JR
Carcinogenesis; 1997 Jun; 18(6):1203-14. PubMed ID: 9214604
[TBL] [Abstract][Full Text] [Related]
20. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
Gauthier-Landry L; Bélanger A; Barbier O
J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
